Company Advaxis, Inc. Nasdaq
Equities
US0076242082
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ken Berlin
CEO | Chief Executive Officer | 59 | 18-04-22 |
- | - | ||
- | - | ||
50 | - | ||
- | - | ||
- | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
CHM | Chairman | 64 | 13-07-15 |
Roni Appel
CEO | Chief Executive Officer | 57 | 04-10-31 |
Murray Goldberg
BRD | Director/Board Member | 79 | 23-01-18 |
Robert Spiegel
BRD | Director/Board Member | 73 | 23-01-18 |
- | - | ||
Ken Berlin
CEO | Chief Executive Officer | 59 | 18-04-22 |
Director/Board Member | 53 | 23-01-18 | |
58 | - | ||
44 | - |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.9B | |
+47.07% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |